Award recordCONTRACT

LAKEVIEW DIAGNOSTIC

PIID VA25017J1010· VHA· 583-INDIANAPOLIS(00583)· 6505 · DRUGS AND BIOLOGICALS· FY2017· $63,371 net obligations· UEI D6G2N35AECL9· MI

Description

TC99M SESTAMIBI (RADIOPHARMACEUTICALS) MODIFICATION ISSUED TO REMOVE UNUSED FUNDING AND CLOSE OUT THIS ACTION.

Base award description: TC99M SESTAMIBI (RADIOPHARMACEUTICALS)

First action · last action
2016-12-13 · 2017-08-01
Transactions
2
First transaction's obligation
$112,650
Base + all options value (sum of deltas)
$63,371
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
VA25114D0025
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$112,650$0Base award · 2016-12-13 · this action $112,650 · running total $112,650Modification P00001 · 2017-08-01 · this action -$49,279 · running total $63,371
  • Base2016-12-13+$112,650= $112,650
  • Mod P000012017-08-01-$49,279= $63,371
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2016-12-13+$112,650$112,650TC99M SESTAMIBI (RADIOPHARMACEUTICALS)
Mod P00001· CLOSE OUT2017-08-01−$49,279$63,371TC99M SESTAMIBI (RADIOPHARMACEUTICALS) MODIFICATION ISSUED TO REMOVE UNUSED FUNDING AND CLOSE OUT THIS ACTION.

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI D6G2N35AECL9)

AwardOffice · PSC / listingNet obligationsFY
VA25017J1012553-DETROIT (00553) · 6505 · DRUGS AND BIOLOGICALS$84,916FY2017
VA25116J0306553-DETROIT (00553) · 6505 · DRUGS AND BIOLOGICALS$174,718FY2016
VA25116J0262553-DETROIT (00553) · 6505 · DRUGS AND BIOLOGICALS$112,861FY2016
VA25115J0458553-DETROIT (00553) · 6505 · DRUGS AND BIOLOGICALS$137,350FY2015
VA25115J0370553-DETROIT · 6505 · DRUGS AND BIOLOGICALS$117,675FY2015
VA25114J0639553-DETROIT · 6505 · DRUGS AND BIOLOGICALS$101,131FY2014

Other recipients under 6505 from 583-INDIANAPOLIS(00583) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C25018F0290ABBOTT LABORATORIES INC.583-INDIANAPOLIS(00583)$13,793FY2018
VA25017F4218ALEXION PHARMACEUTICALS INC583-INDIANAPOLIS(00583)$55,584FY2017
VA25017J4216PFIZER INC583-INDIANAPOLIS(00583)$14,554FY2017
VA25017J4118SHIRE US INC.583-INDIANAPOLIS(00583)$41,697FY2017
VA25017P3729MEDI-PHYSICS, INC.583-INDIANAPOLIS(00583)$100,223FY2017

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25017J1010_3600_VA25114D0025_3600 · retrieved 2026-09-27.